713463006: Carfilzomib (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Immunomodulator\Proteasome inhibitor\Carfilzomib

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Immunologic agent (substance)\Carfilzomib
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Antineoplastic agent (substance)\Proteasome inhibitor\Carfilzomib

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2016. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Carfilzomib	Is a	Proteasome inhibitor	true	Inferred relationship	Some
Carfilzomib	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Proteasome inhibitor (disposition)	true	Inferred relationship	Some
Carfilzomib	Is a	Immunologic agent (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing carfilzomib (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Carfilzomib	Inferred relationship	Some	1
Carfilzomib-containing product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Carfilzomib	Inferred relationship	Some	1
Carfilzomib only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Carfilzomib	Inferred relationship	Some	1
Carfilzomib only product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Carfilzomib	Inferred relationship	Some	1
Product containing precisely carfilzomib 60 milligram/1 vial powder for conventional release solution for infusion (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Carfilzomib	Inferred relationship	Some	1
Product containing precisely carfilzomib 60 milligram/1 vial powder for conventional release solution for infusion (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Carfilzomib	Inferred relationship	Some	1
Product containing precisely carfilzomib 10 milligram/1 vial powder for conventional release solution for infusion (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Carfilzomib	Inferred relationship	Some	1
Product containing precisely carfilzomib 10 milligram/1 vial powder for conventional release solution for infusion (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Carfilzomib	Inferred relationship	Some	1
Product containing precisely carfilzomib 30 milligram/1 vial powder for conventional release solution for infusion (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Carfilzomib	Inferred relationship	Some	1
Product containing precisely carfilzomib 30 milligram/1 vial powder for conventional release solution for infusion (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Carfilzomib	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3289420010	Carfilzomib	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3289481011	Carfilzomib (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
57081000195118	carfilzomib	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
797921000172116	carfilzomib	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
72221000195111	Carfilzomib	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module